Collegium Pharmaceutical, Inc.
$34.31
▼
-2.83%
2026-04-21 06:10:00
www.collegiumpharma.com
NMS: COLL
Explore Collegium Pharmaceutical, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$1.09 B
Current Price
$34.31
52W High / Low
$50.79 / $25.86
Stock P/E
17.33
Book Value
$9.51
Dividend Yield
—
ROCE
14.67%
ROE
23.7%
Face Value
—
EPS
$1.73
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
423
Beta
0.77
Debt / Equity
310.41
Current Ratio
1.57
Quick Ratio
1.48
Forward P/E
5.55
Price / Sales
1.47
Enterprise Value
$1.68 B
EV / EBITDA
4
EV / Revenue
2.15
Rating
None
Target Price
$54.17
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
Cons
- Leverage is relatively high.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ANI Pharmaceuticals, Inc. | $81.73 | 23.13 | $1.81 B | 0.06% | 6.99% | 16.16% | $99.5 / $56.71 | $25.8 |
| 2. | Supernus Pharmaceuticals, Inc. | $51.25 | — | $2.92 B | — | -3.31% | -3.68% | $59.68 / $29.16 | $18.48 |
| 3. | Gelteq Limited | $0.7 | — | $7.5 M | — | -31.25% | -42.99% | $4.11 / $0.64 | $1.09 |
| 4. | Talphera, Inc. | $0.78 | — | $40.17 M | — | -52.04% | -1.15% | $1.57 / $0.38 | $0.34 |
| 5. | Lantheus Holdings, Inc. | $83.97 | 23.41 | $5.47 B | — | 16.66% | 21.45% | $108.91 / $47.25 | $16.87 |
| 6. | Organogenesis Holdings Inc. | $2.52 | 8.75 | $324.17 M | — | 11.21% | 9.04% | $7.08 / $2.21 | $2.36 |
| 7. | Caring Brands, Inc. | $1.25 | — | — | — | -157.44% | -2.17% | $6 / $0.06 | $0.14 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 205.45 M | 209.36 M | 188 M | 177.76 M | 181.95 M | — |
| Operating Profit | 60.74 M | 62.07 M | 34.75 M | 20.9 M | 35.2 M | — |
| Net Profit | 16.96 M | 31.51 M | 11.98 M | 2.42 M | 12.54 M | — |
| EPS in Rs | 0.52 | 0.97 | 0.37 | 0.07 | 0.39 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 780.57 M | 631.45 M | 566.77 M | 463.93 M |
| Operating Profit | 178.45 M | 166.98 M | 166.96 M | 33.32 M |
| Net Profit | 62.87 M | 69.19 M | 48.16 M | -25 M |
| EPS in Rs | 1.94 | 2.14 | 1.49 | -0.77 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 1.66 B | 1.66 B | 1.14 B | 1.17 B |
| Total Liabilities | 1.36 B | 1.43 B | 947.88 M | 979.29 M |
| Equity | 301.68 M | 228.84 M | 195.43 M | 194.84 M |
| Current Assets | 691.41 M | 482.26 M | 537.6 M | 419.99 M |
| Current Liabilities | 440.03 M | 509.51 M | 457.92 M | 433.73 M |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 329.32 M | 204.98 M | 274.75 M | 124.23 M |
| Investing CF | -63.53 M | -287.76 M | -70.81 M | -573.69 M |
| Financing CF | -110.25 M | -60.6 M | -140.18 M | 436.72 M |
| Free CF | 327.58 M | 203.33 M | 274.29 M | 122.61 M |
| Capex | -1.74 M | -1.65 M | -0.46 M | -1.62 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 11.41% | 22.17% | — | — |
| Earnings Growth % | 43.68% | 292.6% | — | — |
| Profit Margin % | 10.96% | 8.5% | -5.39% | — |
| Operating Margin % | 26.44% | 29.46% | 7.18% | — |
| Gross Margin % | 59.76% | 57.55% | 45.15% | — |
| EBITDA Margin % | 54.11% | 54.4% | 37.36% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.